Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes

被引:64
作者
Florian, S
Krauth, MT
Simonitsch-Klupp, I
Sperr, WR
Fritsche-Polanz, R
Sonneck, K
Födinger, M
Agis, H
Böhm, A
Wimazal, F
Horny, HP
Valent, P
机构
[1] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, AT-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Clin Pathol, AT-1090 Vienna, Austria
[3] Med Univ Vienna, Inst Clin Med, AT-1090 Vienna, Austria
[4] Med Univ Vienna, Chem Lab Diagnost, AT-1090 Vienna, Austria
[5] Med Univ Lubeck, Inst Pathol, D-23538 Lubeck, Germany
关键词
mastocytosis; classification; tryptase; anaphylaxis; CD25; c-kit mutation;
D O I
10.1159/000083954
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: In contrast to aggressive mastocytosis, patients with indolent systemic mastocytosis ( ISM) usually present with urticaria pigmentosa- like skin lesions. In those who lack skin lesions, mastocytosis is often overlooked or confused with endocrinologic, allergic, or other internal disorders. Case Report and Results: We report on a 33-year-old male patient in whom severe hypotensive episodes occurred after contact with ants or yellow jackets. Since no specific IgE was detected, the serum tryptase concentration was measured and found to be clearly elevated ( 70 ng/ml). Consecutive staging and examination of the bone marrow revealed ISM. The patient was advised to circumvent insect contact, to take antihistamines on demand, and to carry an epinephrine self-injector for emergency events. In a retrospective analysis of 40 patients seen between 1988 and 2003, only 2 had a life-threatening mediator-related episode before ISM was diagnosed. Conclusions: Our report confirms the diagnostic value of tryptase in patients with suspected mastocytosis. In addition, the report suggests that the lack of typical skin lesions does not exclude an indolent form of mastocytosis even if the serum tryptase is clearly elevated. Finally, our case further shows that mastocytosis can be an important differential diagnosis to be considered in patients with unexplained anaphylactoid or other mediator-related symptoms. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:273 / 280
页数:8
相关论文
共 39 条
[1]   Systemic mastocytosis [J].
Akin, C ;
Metcalfe, DD .
ANNUAL REVIEW OF MEDICINE, 2004, 55 :419-432
[2]   SYSTEMIC MASTOCYTOSIS [J].
AUSTEN, KF .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (09) :639-640
[3]   ESTABLISHMENT OF AN IMMATURE MAST-CELL LINE FROM A PATIENT WITH MAST-CELL LEUKEMIA [J].
BUTTERFIELD, JH ;
WEILER, D ;
DEWALD, G ;
GLEICH, GJ .
LEUKEMIA RESEARCH, 1988, 12 (04) :345-355
[4]   Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis:: A possible explanation for divergent clinical behavior [J].
Büttner, C ;
Henz, BM ;
Welker, P ;
Sepp, NT ;
Grabbe, J .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (06) :1227-1231
[5]   NATURAL COURSE OF URTICARIA PIGMENTOSA - ANALYSIS AND FOLLOW-UP 112 CASES [J].
CAPLAN, RM .
ARCHIVES OF DERMATOLOGY, 1963, 87 (02) :146-&
[6]  
Elberink JNGO, 1997, J ALLERGY CLIN IMMUN, V99, P153, DOI 10.1016/S0091-6749(97)70314-2
[7]   Mastocytosis: current concepts in diagnosis and treatment [J].
Escribano, L ;
Akin, C ;
Castells, M ;
Orfao, A ;
Metcalfe, DD .
ANNALS OF HEMATOLOGY, 2002, 81 (12) :677-690
[8]   Indolent systemic mast cell disease in adults:: Immunophenotypic characterization of bone marrow mast cells and its diagnostic implications [J].
Escribano, L ;
Orfao, A ;
Díaz-Agustin, B ;
Villarrubia, J ;
Cerveró, C ;
López, A ;
Marcos, MAG ;
Bellas, C ;
Fernández-Cañadas, S ;
Cuevas, M ;
Sánchez, A ;
Velasco, JL ;
Navarro, JL ;
San Miguel, JF .
BLOOD, 1998, 91 (08) :2731-2736
[9]   Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis [J].
Fritsche-Polanz, R ;
Jordan, JH ;
Feix, A ;
Sperr, WR ;
Sunder-Plassmann, G ;
Valent, P ;
Födinger, M .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (02) :357-364
[10]   A case of smouldering mastocytosis with peripheral blood eosinophilia and lymphadenopathy [J].
Hauswirth, AW ;
Sperr, WR ;
Ghannadan, M ;
Schernthaner, GH ;
Jordan, JH ;
Fritsche-Polanz, R ;
Simonitsch-Klupp, I ;
Födinger, M ;
Lechner, K ;
Valent, P .
LEUKEMIA RESEARCH, 2002, 26 (06) :601-606